ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,459.10
1.11%
US Tech 100
18,514.00
1.00%
Dow Jones
40,589.34
1.64%
Brent Oil
79.745
0.00%
Bitcoin
67,891.04
-0.03%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Castle Biosciences Inc (CSTL) Quote

Castle Biosciences Inc

Castle Biosciences Inc (CSTL)

NASDAQ
21.06
1.75
(9.06%)
Closed July 27 4:00PM
Delayed by 15 minutes
21.06
-0.01
(-0.05%)
After Hours: 5:30PM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
21.06
Bid
20.70
Ask
23.00
Volume
498,401
19.16 Day's Range 21.08
12.07 52 Week Range 25.91
Market Cap
581.407M
Previous Close
19.31
Open
19.71
Last Trade
49
@
21.06
Last Trade Time
Financial Volume
$ 10,029,735
VWAP
20.1238
Average Volume (3m)
316,802
Shares Outstanding
27,607,183
Dividend Yield
-
PE Ratio
-10.12
Earnings Per Share (EPS)
-2.08
Revenue
219.79M
Net Profit
-57.47M

About Castle Biosciences Inc

Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanom... Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others. Show more

Sector
Medical Laboratories
Industry
Medical Laboratories
Website
www.castlebiosciences.com
Headquarters
Wilmington, Delaware, USA
Founded
1970
Castle Biosciences Inc is listed in the Medical Laboratories sector of the NASDAQ with ticker CSTL. The last closing price for Castle Biosciences was $19.31. Over the last year, Castle Biosciences shares have traded in a share price range of $ 12.07 to $ 25.91.

Castle Biosciences currently has 27,607,183 shares outstanding. The market capitalization of Castle Biosciences is $533.09 million. Castle Biosciences has a price to earnings ratio (PE ratio) of -10.12.

Castle Biosciences (CSTL) Options Flow Summary

CSTL Options Flow

Overall Flow

Bullish

Net Premium

29k

Calls / Puts

100.00%

Buys / Sells

0.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

CSTL Latest News

More News

Castle Biosciences and Skin Cancer Survivor Teddi Mellencamp Arroyave Launch Campaign to Increase Awareness of Melanoma

Campaign will focus on empowering patients impacted by melanoma Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, has joined...

July 22 2024
Business Wire

Form 4 - Statement of changes in beneficial ownership of securities

July 16 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

July 16 2024
Edgar (US Regulatory)

Castle Biosciences to Release Second Quarter 2024 Financial Results and Host Conference Call on Monday, Aug. 5, 2024

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it will release its financial results for the second...

July 15 2024
Business Wire

Castle Biosciences Honored with Top Workplaces Awards

Castle earns recognition as an Arizona Top Workplace, a national Healthcare Industry Top Workplace and receives five Top Workplaces Culture Excellence Awards Castle Biosciences, Inc. (Nasdaq:...

July 11 2024
Business Wire

Recent AGA Clinical Practice Guideline Acknowledges That Individuals Who May Be at Increased Risk of Progression to Esophageal Cancer Might Be Identified Using Tissue-Based Biomarkers, Particularly Castle Biosciences’ TissueCypher® Test

Castle’s TissueCypher test has been shown to improve the risk stratification of patients with Barrett’s esophagus (BE)1,2 Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health...

June 24 2024
Business Wire

Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that on June 14, 2024, the Compensation Committee of its...

June 20 2024
Business Wire

Castle Biosciences’ Founder, President and CEO Derek Maetzold Named an EY Entrepreneur Of The Year® 2024 Gulf South Award Winner

Maetzold selected as a winner of Ernst & Young’s prestigious annual awards among 48 visionary finalists in the Gulf South region, encompassing Central and South Texas, Louisiana and...

June 14 2024
Business Wire

Form 4 - Statement of changes in beneficial ownership of securities

June 04 2024
Edgar (US Regulatory)

Castle Biosciences to Present New Data at 2024 ASCO® Annual Meeting Highlighting Use of DecisionDx®-Melanoma to Identify Early-Stage Melanoma Patients at High Risk of Metastasis to the Central Nervous System to Prompt Use of Imaging Surveillance

Castle to present a second poster on its DecisionDx®-UM test sharing data from an ongoing prospective, multi-center study of patients with uveal melanoma (UM) led by the Collaborative Ocular...

May 30 2024
Business Wire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
12.3612.620320855618.721.0818.725256919.86098908CS
4-0.21-0.9873060648821.2721.9816.96540118019.18612157CS
12-2.44-10.382978723423.525.9116.96531680221.63161868CS
260.52.4319066147920.5625.9116.96527124821.65005505CS
525.7537.557152188115.3125.9112.0726765419.70445677CS
156-47.89-69.456127628768.9578.5859.260128453225.48709413CS
260-0.44-2.0465116279121.5107.699.260125324333.92817126CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WINTWindtree Therapeutics Inc
$ 8.24
(150.46%)
48.57M
BFIBurgerFi International Inc
$ 0.4206
(97.37%)
313.59M
NBSTWNewbury Street Acquisition Corporation
$ 0.1349
(92.71%)
122.1k
YIBOPlanet Image International Ltd
$ 2.915
(53.43%)
260.07k
CREVCarbon Revolution Public Ltd
$ 9.00
(45.87%)
8.06M
NMHINatures Miracle Holding Inc
$ 0.2035
(-48.06%)
7.69M
TANHTantech Holdings Ltd
$ 0.2585
(-47.23%)
6.75M
DXCMDexCom Inc
$ 64.00
(-40.66%)
53.92M
PSIGPS International Group Ltd
$ 1.42
(-31.40%)
716.26k
POAIPredictive Oncology Inc
$ 1.36
(-27.27%)
6.02M
SLNASelina Hospitality PLC
$ 0.0305
(-18.88%)
408.61M
BFIBurgerFi International Inc
$ 0.4206
(97.37%)
313.59M
NVDANVIDIA Corporation
$ 113.06
(0.69%)
293.33M
SQQQProShares UltraPro Short QQQ
$ 9.10
(-2.88%)
176.49M
SGMOSangamo Therapeutics Inc
$ 0.8612
(28.15%)
123.71M

Discussion

View Full Feed
BDEZ BDEZ 34 seconds ago
Who runs the @TeamTrump account?

https://x.com/hodgetwins/status/1816635909107835344
ATDS FB CULT ATDS FB CULT 2 minutes ago
So you are saying the elite is divided? Some hold bitcoin, but are stuck with it. So that means, some elite got fooled into crypto.

While real brokers (or elite) are avoiding crypto.

So where do the 'real' elite stand on crypto. Because all major banks and financia
BTCUSD
Jimmy Joe Jimmy Joe 7 minutes ago
I mean is it hard to find a company that is profitable, or are we captives of $DBMM........

He knows exactly what is going on and only pretends when he makes lame arguments against $DBMM.

Funny thing is how he understands the litigation in NetList cases yet can't seem
DBMM
sharky sharky 8 minutes ago
9-1 buys vs sells on Friday. Accumulation picking up

$BLEG
BLEG
janice shell janice shell 9 minutes ago
LOLOLOLOL!!

Was writing a reply to your PM, but IHub PMs are down for maintenance. So I'll just post it here. Don't let the fascist moderators and admins know!!

Jesus. They're threatened by EVERYTHING. They want to be allowed to explore posters' "motivations". WTF? Ho
Murphydog25 Murphydog25 13 minutes ago
Your missing the point she's been back on X in the last 2 hours to answer no to RS but won't answer my and another persons questions about CIVET USA 🤷‍♂️ I can't find any information about it nor can you 🤷‍♂️
NWPN
noradio noradio 14 minutes ago
He has 600 posts on this board, you have 6000... Perhaps it is you who should be moving on.🤔
ERHE
jeunke22 jeunke22 15 minutes ago
Renewal of shelf offering to 100 Mio makes all business sense. Company has great cash ( until deep into 2025) position, has been very frugal in tapping funds from existing, running shelf from Roth and LPC. Both sources together could still provide around 40-45 mio under the ‘ old’ shelf and …
LWLG
spdpro spdpro 20 minutes ago
another good btc chart > and other stuff
https://www.centralcharts.com/en/charts/6863-btc-usd
https://www.centralcharts.com/en/charts/8595-nasdaq-composite
rockhunter rockhunter 21 minutes ago
Crazy to think that no one on here has even had no thoughts that if this oportunity is real... that there is actual millions... possibly billions... of dollars within our reach... that this could just be fun money for these new operators. Toying you all for a bit... stealing your shares.. running yo
HIRU
Welcome2Pinkyland Welcome2Pinkyland 22 minutes ago
For sure- superior grammar skills and the queen of the Ihub fraud team. The total package.
Truth and Transparency Truth and Transparency 22 minutes ago
Unfortunately, the amazing businessman that we believed Mr. Mark Smith to be is revealing himself to be the Mr. Bean of businessmen
NB
tmcfo tmcfo 23 minutes ago
You the man Adjusted! I hope they are nice enough to let you in as a major shareholder..buying more next week
MVNT
StocktonCA StocktonCA 24 minutes ago
very intrigueing, they added shares bc the purchaser knew the value will increase once significant trials have been completed. this company is way undervalued. big players in the know have loaded the boat bc they are aware of the exponential increase in bound.
GLTA longs who stayed on the bul
RSPI
BDEZ BDEZ 25 minutes ago
Thoughts? https://x.com/its_The_Dr/status/1816638114820972750
janice shell janice shell 26 minutes ago
❌️ is killing it....wouldn't it be sensible for us to give them a decent run for their money...we have the infrastructure and staff to do it

Srsly?? X is funded by one of the richest men in the world. IHub was created as a site to service penny plungers. It was initially quite succes
fuagf fuagf 27 minutes ago
Yep, knew that was your point.

2:34pm here. Enough. Cheers.
fuagf fuagf 28 minutes ago
Forever t'will be. Years ago something clicked for me, if an organization had a word like "freedom"
or "liberty" in it's name then watch out baby, it ain't good for but a relative wealthy few.

"There we go with the secretive opposite meaning group names. Again."
Nezitic Nezitic 29 minutes ago
Lol
PSRU
lakers17 lakers17 31 minutes ago
It’s a historic week for the cryptocurrency markets with spot ether exchange-traded funds making their debut.

Franklin Templeton is one of the nine spot ether ETF applicants which got approval Tuesday from the Securities and Exchange commission.

The firm is behind the F
The Night Stalker The Night Stalker 32 minutes ago
STAL big history of runs
STAL
Acme Investments Acme Investments 33 minutes ago
Well let's throw Tim Sykes into the conversation while we're at it!! Sell courses get rich, actually trade 99% fail!!
HIRU
BDEZ BDEZ 35 minutes ago
She can pretend she wasn’t the border czar (she was)

https://x.com/RealJamesWoods/status/1816872909224444195

Your Recent History

NASDAQ
CSTL
Castle Biosciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved